Resultados da pesquisa - Isabel Arrillaga‐Romany

  • A mostrar 1 - 19 resultados de 19
Refinar resultados
  1. 1
    Long‐lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of µ‐opioid receptor mRNA and FosB/ΔFosB immunoreactivity

    Long‐lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of µ‐opioid receptor mRNA and FosB/ΔFosB immunoreactivity Por Ella M. Nikulina, Isabel Arrillaga‐Romany, Klaus A. Miczek, Ronald P. Hammer

    Publicado em 2008
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma

    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma Por Isabel Arrillaga‐Romany, S. Andrew, Joshua E. Allen, Wolfgang Oster, Patrick Y. Wen, Tracy T. Batchelor

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Accelerated progression of IDH mutant glioma after first recurrence

    Accelerated progression of IDH mutant glioma after first recurrence Por Julie J. Miller, Franziska Loebel, Tareq A. Juratli, Shilpa S. Tummala, Erik A. Williams, Tracy T. Batchelor, Isabel Arrillaga‐Romany, Daniel P. Cahill

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma

    Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma Por Jeremy S. Abramson, Brianne McGree, Sarah Noyes, Sean Plummer, Curtis Wong, Yi‐Bin Chen, Edwin L. Palmer, Tina Albertson, Judith A. Ferry, Isabel Arrillaga‐Romany

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  5. 5
    Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition

    Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition Por Roberta Rasetti, Venkata S. Mattay, Beth Stankevich, Kelsey Skjei, Giuseppe Blasi, Fabio Sambataro, Isabel Arrillaga‐Romany, Terry E. Goldberg, Joseph H. Callicott, José Apud, Daniel R. Weinberger

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Biological activity of weekly ONC201 in adult recurrent glioblastoma patients

    Biological activity of weekly ONC201 in adult recurrent glioblastoma patients Por Isabel Arrillaga‐Romany, Yazmín Odia, Varun V. Prabhu, Rohinton S. Tarapore, Krystal Merdinger, Martin Stogniew, Wolfgang Oster, Joshua E. Allen, Minesh P. Mehta, Tracy T. Batchelor, Patrick Y. Wen

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate

    Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate Por Ovidiu C. Andronesi, Isabel Arrillaga‐Romany, Ina Ly, Wolfgang Bogner, Eva Ratai, Kara Reitz, A. John Iafrate, Jörg Dietrich, Elizabeth R. Gerstner, S. Andrew, Bruce R. Rosen, Patrick Y. Wen, Daniel P. Cahill, Tracy T. Batchelor

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma

    ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma Por Isabel Arrillaga‐Romany, Andrew B. Lassman, Susan L. McGovern, Sabine Mueller, Burt Nabors, Martin J. van den Bent, Michael A. Vogelbaum, Joshua E. Allen, Allen S. Melemed, Rohinton S. Tarapore, Patrick Y. Wen, Timothy F. Cloughesy

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

    Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells Por Philipp Karschnia, Justin T. Jordan, Deborah Forst, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Joachim M. Baehring, Nathan F. Clement, L. Nicolas Gonzalez Castro, Aline Herlopian, Marcela V. Maus, Michaela H. Schwaiblmair, Jacob D. Soumerai, Ronald W. Takvorian, Ephraim P. Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Matthew J. Frigault, Jörg Dietrich

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

    Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma Por Brian M. Alexander, Lorenzo Trippa, Sarah Gaffey, Isabel Arrillaga‐Romany, Eudocia Q. Lee, Mikael L. Rinne, Manmeet S. Ahluwalia, Howard Colman, Geoffrey Fell, Evanthia Galanis, John de Groot, Jan Drappatz, Andrew B. Lassman, David M. Meredith, Burt Nabors, Sandro Santagata, David Schiff, Mary Welch, Keith L. Ligon, Patrick Y. Wen

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

    Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial Por Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen, Jennie Taylor, Elizabeth A. Maher, Isabel Arrillaga‐Romany, Katherine B. Peters, Benjamin M. Ellingson, Marc K. Rosenblum, Saewon Chun, Kha Le, Anna M. Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S. Pandya, Islam Hassan, Lori Steelman, Jennifer Clarke, Timothy F. Cloughesy

    Publicado em 2023
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism

    Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism Por Varun V. Prabhu, Neel S. Madhukar, Coryandar Gilvary, C. Leah B. Kline, Sophie Oster, Wafik S. El‐Deiry, Olivier Elemento, Faye Doherty, Alexander VanEngelenburg, Jessica Durrant, Rohinton S. Tarapore, Sean Deacon, Neil Charter, Jinkyu Jung, Deric M. Park, Mark R. Gilbert, Jessica M. Rusert, Robert J. Wechsler‐Reya, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Patrick Y. Wen, Wolfgang Oster, Joshua E. Allen

    Publicado em 2018
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas

    Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas Por Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy Wang, April F. Eichler, Ugonma Chukwueke, Deborah Forst, Isabel Arrillaga‐Romany, Jörg Dietrich, Zachary Corbin, Jennifer Moliterno, Joachim M. Baehring, Michael G. White, Kevin Lou, Juliana M. Larson, Magali de Sauvage, Kathryn Evancic, Joana L. Mora, Naema Nayyar, Jay S. Loeffler, Kevin Oh, Helen A. Shih, William T. Curry, Daniel P. Cahill, Fred G. Barker, Elizabeth R. Gerstner, Sandro Santagata

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

    Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma Por Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

    ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma Por Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia, Dolly Aguilera, Joshua E. Allen, Tracy T. Batchelor, Nicholas Butowski, Clark C. Chen, Timothy F. Cloughesy, Andrew Cluster, John de Groot, Karan Dixit, Jerome Graber, Aya Haggiagi, Rebecca A. Harrison, Albert Kheradpour, Lindsay Kilburn, Sylvia C. Kurz, Guangrong Lu, Tobey J. MacDonald, Minesh P. Mehta, Allen S. Melemed, Phioanh L. Nghiemphu, Samuel Ramage, Nicole Shonka, Ashley Sumrall, Rohinton S. Tarapore, Lynne P. Taylor, Yoshie Umemura, Patrick Y. Wen

    Publicado em 2024
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

    Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma Por Avishay Spitzer, Simon Gritsch, Masashi Nomura, Alexander Jucht, Jérôme Fortin, Ramya Raviram, Hannah Weisman, L. Nicolas Gonzalez Castro, Nicholas Druck, Rony Chanoch-Myers, John J. Y. Lee, Ravindra Mylvaganam, Rachel L. Servis, Jeremy Man Fung, Christine K. Lee, Hiroaki Nagashima, Julie J. Miller, Isabel Arrillaga‐Romany, David N. Louis, Hiroaki Wakimoto, Will Pisano, Patrick Y. Wen, Tak W. Mak, Marc Sanson, Mehdi Touat, Dan A. Landau, Keith L. Ligon, Daniel P. Cahill, Mario L. Suvà, Itay Tirosh

    Publicado em 2024
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

    Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma Por Benjamin M. Ellingson, Lauren E. Abrey, Sarah J. Nelson, Timothy J. Kaufmann, Josep Garcia, Olivier Chinot, Frank Saran, Ryo Nishikawa, Roger Henriksson, W. P. Mason, Wolfgang Wick, Nicholas Butowski, Keith L. Ligon, Elizabeth R. Gerstner, Howard Colman, John de Groot, Susan M. Chang, Ingo K. Mellinghoff, Robert J. Young, Brian M. Alexander, Rivka R. Colen, Jennie Taylor, Isabel Arrillaga‐Romany, Arnav Mehta, Raymond Y. Huang, Whitney B. Pope, David A. Reardon, Tracy T. Batchelor, Michael D. Prados, Evanthia Galanis, Patrick Y. Wen, Timothy F. Cloughesy

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location

    The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location Por Ilon Liu, Li Jiang, Erik Samuelsson, Sergio Marco Salas, Alexander Beck, Olivia A. Hack, Da-Eun Jeong, McKenzie Shaw, Bernhard Englinger, Jenna LaBelle, Hafsa M. Mire, Sibylle Madlener, Lisa Mayr, Michael A. Quezada, Maria Trissal, Eshini Panditharatna, Kati Ernst, Jayne Vogelzang, Taylor Gatesman, Matthew Halbert, Hana Pálová, Petra Pokorná, Jaroslav Štěrba, Ondřej Slabý, René Geyeregger, Aarón Díaz, Izac J. Findlay, Matthew D. Dun, Adam Resnick, Mario L. Suvà, David Jones, Sameer Agnihotri, Jessica Svedlund, Carl Koschmann, Christine Haberler, Thomas Czech, Irene Slavc, Jennifer Cotter, Keith L. Ligon, Sanda Alexandrescu, W.K. Alfred Yung, Isabel Arrillaga‐Romany, Johannes Gojo, Michelle Monje, Mats Nilsson, Mariella G. Filbin

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways Por Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S. Tarapore, Samuel Ramage, Andrew Chi, Patrick Y. Wen, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca A. Harrison, John de Groot, Minesh P. Mehta, Matthew D. Hall, Doured Daghistani, Timothy F. Cloughesy, Benjamin M. Ellingson, Kévin Beccaria, Pascale Varlet, Michelle M. Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie L. Mottl, Rodrigo T. Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander R. Judkins, Daniel Wahl, Costas A. Lyssiotis, Daniel de la Nava, Marta M. Alonso, Augustine Eze, Jasper Spitzer, Susanne V. Schmidt, Ryan J. Duchatel, Matthew D. Dun, Jason E. Cain, Li Jiang, Sylwia A. Stopka, Gerard Baquer, Michael S. Regan, Mariella G. Filbin, Nathalie Y.R. Agar, Lili Zhao, Chandan Kumar‐Sinha, Rajen Mody, Arul M. Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Nand Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua E. Allen, Yazmín Odia, Sharon L. Gardner, Carl Koschmann

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: